Ongoing phase II multi-arm stratified trial MiST (Mesothelioma Stratified Therapy, ClinicalTrials.gov Identifier: NCT03654833) is currently investigating the AtezoBev combination in MPlM with PD-L1 overexpression. Here, CD274 is linked to mesothelioma.